Real-World Analysis of the Efficacy of Rebiopsy and EGFR Mutation Test of Tissue and Plasma Samples in Drug-Resistant Non-Small Cell Lung Cancer

PURPOSE: Standard treatment for cases of non-small cell lung cancer (NSCLC) exhibiting acquired drug resistance includes tumor rebiopsy, epidermal growth factor receptor (EGFR) mutation testing (e.g., for T790M mutations), and the subsequent administration of third-generation EGFR-tyrosine kinase in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Yonsei Med J
Main Authors: Hong, Min Hee, Kim, Hye Ryun, Ahn, Beung-Chul, Heo, Su Jin, Kim, Jee Hung, Cho, Byoung Chul
Formato: Artigo
Idioma:Inglês
Publicado em: Yonsei University College of Medicine 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6536394/
https://ncbi.nlm.nih.gov/pubmed/31124335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2019.60.6.525
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados